Long-acting Recombinant FSH
Single injection for 7-day efficacy, improved patient compliance
Single injection for 7-day efficacy, improved patient compliance
Source: Produced via recombinant DNA technology (CTP fusion protein expressed in CHO cells)
- Single injection provides 7 days of effective action, replacing traditional 7-day daily injection regimen
- Phase III clinical data: Oocytes retrieved, high-quality embryo rate, and pregnancy outcomes are non-inferior to short-acting rFSH
- Patient compliance significantly improved (93% of patients preferred "once-a-week" regimen)